Healthcare >> CEO Interviews >> July 8, 2002
DR. BIN HUANG is President and Chief Executive Officer of Cytovax
Biotechnologies Inc., a TSX-listed biotech company based in Edmonton,
Alberta. Before joining Cytovax, Dr. Huang was Vice President of
Business Development at Monsanto Canada, where she was responsible for
strategy and business development. Prior to Monsanto, Dr. Huang was Vice
President of R&D at Imutec Pharma Inc., now Lorus Therapeutics Inc. Dr.
Huang has also worked in the investment banking business as a partner
and biotech analyst at Griffiths McBurney and Partners. Profile
Biotechnologies and tell us what you are doing at the present time?
Dr. Huang: Cytovax is a biotechnology company. Our business focus
